Premium
Activated Somatostatin Type 2 Receptors Traffic In Vivo in Central Neurons from Dendrites to the Trans Golgi Before Recycling
Author(s) -
Csaba Zsolt,
Lelouvier Benjamin,
Viollet Cécile,
El Ghouzzi Vincent,
Toyama Kiyoko,
Videau Catherine,
Bernard Véronique,
Dournaud Pascal
Publication year - 2007
Publication title -
traffic
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.677
H-Index - 130
eISSN - 1600-0854
pISSN - 1398-9219
DOI - 10.1111/j.1600-0854.2007.00580.x
Subject(s) - biology , somatostatin receptor , microbiology and biotechnology , receptor , golgi apparatus , endosome , somatostatin , g protein coupled receptor , agonist , endocytic cycle , neuroscience , endocytosis , signal transduction , biochemistry , endoplasmic reticulum
Understanding the trafficking of G‐protein‐coupled receptors (GPCRs) is of particular importance, especially when modifications of the neurochemic environment occur as in pathological or therapeutic circumstances. In the central nervous system, although some GPCRs were reported to internalize in vivo , little is known about their trafficking downstream of the endocytic event. To address this issue, distribution and expression pattern of the major somatostatin receptor subtype, the somatostatin type 2 (sst2), was monitored in the hippocampus using immunofluorescence, autoradiographic and immunogold experiments from 10 minutes to 7 days after in vivo injection of the receptor agonist octreotide. We then analyzed whether postendocytic trafficking of the receptor was dependent upon integrity of the microtubule network using colchicine‐injected animals. Together, our results suggest that upon agonist stimulation, dendritic receptors are retrogradely transported through a microtubule‐dependent mechanism to a trans Golgi domain enriched in the t ‐SNARE syntaxin 6 and trans Golgi network 38 proteins, before recycling. Because we show that the exit rate from the trans Golgi apparatus back to the plasma membrane (hours) is slower than the entry rate (minutes), the neuronal postendocytic trafficking of sst2 receptor is likely to have functional consequences in several neurological diseases in which an increase in somatostatin release occurs.